Yahoo
LSE - Delayed Quote SEK

Bonesupport Holding AB (publ) (0RQO.L)

308.10 -4.20 (-1.34%)
As of 12:29:51 PM GMT. Market Open.
Chart Range Bar
Loading chart for 0RQO.L
  • Previous Close 312.30
  • Open 306.80
  • Bid --
  • Ask --
  • Day's Range 306.80 - 310.00
  • 52 Week Range 167.55 - 339.40
  • Volume 10,466
  • Avg. Volume 36,214
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) --
  • EPS (TTM) -1.27
  • Earnings Date Oct 22, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

www.bonesupport.com

174

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0RQO.L
0.00%
MSCI WORLD (^990100-USD-STRD)
9.23%

1-Year Return

0RQO.L
0.00%
MSCI WORLD (^990100-USD-STRD)
10.11%

3-Year Return

0RQO.L
0.00%
MSCI WORLD (^990100-USD-STRD)
67.81%

5-Year Return

0RQO.L
0.00%
MSCI WORLD (^990100-USD-STRD)
50.64%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 408.83M
Earnings 92.36M
Profit Margin 22.59%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
400M
16.0%
18.0%
20.0%
22.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.40%

  • Return on Assets (ttm)

    20.56%

  • Return on Equity (ttm)

    29.73%

  • Revenue (ttm)

    1.4B

  • Net Income Avi to Common (ttm)

    271.77M

  • Diluted EPS (ttm)

    -1.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    510.52M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    181.43M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: